From elegant neutrals to uplifting brights, welcome the new season with our round-up of the key trends for your home ...
Appointment Strengthens Clinical Leadership as VectorY Prepares to Submit Investigational New Drug Application for VTx-002 in Sporadic ALS by Year-End 2025 ~ VectorY Therapeutics, a biotechnology ...
Fintel reports that on March 31, 2025, UBS downgraded their outlook for Agnico Eagle Mines (NYSE:AEM) from Buy to Neutral.